Browsing by Author

Now showing items 1-3 of 3

A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer

Jones, Robert; Plummer, Ruth; Carter, Louise; Roda, Desamparados; Garralda Cabanas, Elena; Moreno, Victor (American Association for Cancer Research, 2023-01-17)
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies

Hollebecque, Antoine; Salvagni, Stefania; Plummer, Ruth; Niccoli, Patricia; Capdevila Castillon, Jaume; Curigliano, Giuseppe (Wiley, 2022-09-01)
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours

Ameratunga, Malaka; Braña Garcia, Irene; Bono, Petri; Postel-Vinay, Sophie; Plummer, Ruth; Aspegren, John (Springer Nature, 2020-12-08)